⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

LI
LIC MFLIC MF Value Fund - IDCW - Direct PlanDirect · IDCW
₹29.43 as on 30 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricLILIC MF Value Fund - IDCW - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMCLIC MFHDFC MF
CategoryEquity - Value FundEquity - Sectoral Fund - Pharma & Health Care
NAV₹29.43 (30 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★★★★
BenchmarkNIFTY 500 - TRIBSE Health Care - TRI
Fund ManagerMahesh BendreNikhil Mathur
Inception20 Aug 201804 Oct 2023
Returns
1Y11.50%22.64%
3Y16.51%30.41%
5Y12.21%—
Since Inception14.19%29.15%
Risk
17.3314.07
1.100.59
0.631.59
6.6421.67
1.123.48
-14.76%-9.23%
Costs
Expense Ratio1.86%1.03%
Exit LoadNil upto 12% of units and 1% for remaining units on or before 12M, Nil after 12M1% on or before 30D, Nil after 30D
Min SIP₹200₹100
Min Lumpsum₹5,000₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
LIC MF100%
HDFC MF100%
0.0%

Only 0.0% of holdings by weight are common between LIC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Category context: Equity vs Equity. Open the full Screener →